Korsana Biosciences announced its participation in several upcoming investor conferences in November 2026, including events hosted by Guggenheim, Stifel, UBS, and Jefferies. These presentations will feature discussions about the company's progress in developing therapies for neurodegenerative diseases, particularly their lead program KRSA-028 for Alzheimer's disease. Live webcasts will be available on Korsana's website, allowing investors to follow updates on their innovative treatments and clinical progress. This engagement aims to increase investor awareness and support for Korsana's pipeline advancements.
Korsana Biosciences' upcoming investor conferences provide context for health sector activity on Pluang. As of Nov 03, 2026 04:11 WIB, 48 of 150 priced US health stocks rose while 100 fell. Notable movers include Regeneron Pharmaceuticals Inc at USD 927.38 with a 13.27% increase and American Well Corp at USD 12.71 with a 15.15% decrease.
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...
Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...
Centerspace announced a net income of $7.28 per diluted share for Q3 2026, up from $3.19 in the prior year, driven by gains from selling 14 apartment communities. Despite flat same-store revenues, property expenses rose 4.2%, causing a 2.7% decline i...
XAI Floating Rate & Alternative Income Trust announced a monthly dividend of $0.225 per common share, payable on December 1, 2026, unchanged from the previous month. The dividend will be paid to shareholders of record as of November 16, 2026. Distrib...
